Log in to save to my catalogue

Rosuvastatin Reduces L-Type Ca 2+ Current and Alters Contractile Function in Cardiac Myocytes via Mo...

Rosuvastatin Reduces L-Type Ca 2+ Current and Alters Contractile Function in Cardiac Myocytes via Mo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_33565033

Rosuvastatin Reduces L-Type Ca 2+ Current and Alters Contractile Function in Cardiac Myocytes via Modulation of β-Adrenergic Receptor Signaling

About this item

Full title

Rosuvastatin Reduces L-Type Ca 2+ Current and Alters Contractile Function in Cardiac Myocytes via Modulation of β-Adrenergic Receptor Signaling

Publisher

United States

Journal title

Cardiovascular toxicology, 2021-05, Vol.21 (5), p.422

Language

English

Formats

Publication information

Publisher

United States

More information

Scope and Contents

Contents

Rosuvastatin is one of the most used statins to lower plasma cholesterol levels. Although previous studies have reported remarkable cardiovascular effects of rosuvastatin (RSV), the mechanisms of these effects are largely unknown. In this study, we investigated the acute effects of RSV on L-type Ca
currents and contractile function of ventricula...

Alternative Titles

Full title

Rosuvastatin Reduces L-Type Ca 2+ Current and Alters Contractile Function in Cardiac Myocytes via Modulation of β-Adrenergic Receptor Signaling

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_33565033

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_33565033

Other Identifiers

E-ISSN

1559-0259

DOI

10.1007/s12012-021-09642-5

How to access this item